nature.com search

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

nature
search

Search My Account Login

advanced

where the list of authors contains where the title contains

Refine your results by…

volume

start page / article no.

Filters

Filter By:

Article type

Check one or more article types to show results from those article types only.

Research (6)

Journal

Check one or more journals to show results from those journals only.

Leukemia (3)
Nature Structural & Molecular Biology (2)
British Journal of Cancer (1)
Bone Marrow Transplantation (1)

Choose more journals

Subject Check one or more subjects to show results from those subjects only.

Cell transplantation (1)
Chronic lymphocytic leukaemia (1)
Health care (1)
Medical research (1)
Molecularly targeted therapy (1)

Date

Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
In the last year
Last 2 years
Last 5 years

Custom date range

Sort by Relevance

Choose a way to sort results.

Relevance
Date — most recent
Date — oldest first

Loading Filters

Showing 1–7 of 7 results

Loading Filters

Research | 12 October 2018 | Open
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
- G. Fraser
- , P. Cramer
- , F. Demirkan
- , R. Santucci Silva
- , S. Grosicki
- , A. Pristupa
- , A. Janssens
- , J. Mayer
- , N. L. Bartlett
- , M.-S. Dilhuydy
- , H. Pylypenko
- , J. Loscertales
- , A. Avigdor
- , S. Rule
- , D. Villa
- , O. Samoilova
- , P. Panagiotidis
- , A. Goy
- , M. A. Pavlovsky
- , C. Karlsson
- , M. Hallek
- , M. Mahler
- , M. Salman
- , S. Sun
- , C. Phelps
- , S. Balasubramanian
- , A. Howes
- & A. Chanan-Khan
Leukemia 33 , 969–980

Rights & permissionsfor article Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma . Opens in a new window.
Research | 2 February 2018 | Open
Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
- S Rule
- , W Jurczak
- , M Jerkeman
- , C Rusconi
- , M Trneny
- , F Offner
- , D Caballero
- , C Joao
- , M Witzens-Harig
- , G Hess
- , I Bence-Bruckler
- , S-G Cho
- , C Thieblemont
- , W Zhou
- , T Henninger
- , J Goldberg
- , J Vermeulen
- & M Dreyling
Leukemia 32 , 1799–1803

Rights & permissionsfor article Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study . Opens in a new window.
Research | 18 July 2014
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma
- S Robinson
- , P Dreger
- , D Caballero
- , P Corradini
- , C Geisler
- , M Ghielmini
- , S Le Gouill
- , E Kimby
- , S Rule
- , U Vitolo
- , M Dreyling
- & O Hermine
Leukemia 29 , 464–473

Rights & permissionsfor article The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma . Opens in a new window.
Research | 1 May 1998
Crystal structure of the RNA-binding domain from transcription termination factor rho
Nature Structural & Molecular Biology 5 , 352–356

Rights & permissionsfor article Crystal structure of the RNA-binding domain from transcription termination factor rho . Opens in a new window.
1 July 1991
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
- JS Whelan
- , CL Davis
- , S Rule
- , M Ranson
- , OP Smith
- , AB Mehta
- , D Catovsky
- , AZS Rohatiner
- & TA Lister
British Journal of Cancer 64 , 120–123

Rights & permissionsfor article Fludarabine phosphate for the treatment of low grade lymphoid malignancy . Opens in a new window.
Research | 23 January 2006
Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect
- R K Dasgupta
- , S Rule
- , P Johnson
- , J Davies
- , A Burnett
- , C Poynton
- , K Wilson
- , G M Smith
- , G Jackson
- , C Richardson
- , E Wareham
- , A C Stars
- , S M Tollerfield
- & G J Morgan
Bone Marrow Transplantation 37 , 455–461

Rights & permissionsfor article Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect . Opens in a new window.
Research | 1 May 1998
The NMR structure of the RNA binding domain of E.coli rho factor suggests possible RNA–protein interactions
Nature Structural & Molecular Biology 5 , 393–399

Rights & permissionsfor article The NMR structure of the RNA binding domain of <i>E.coli</i> rho factor suggests possible RNA–protein interactions . Opens in a new window.

Nature Research menu

Our Journals

Nature
Nature Communications
Nature Protocols
Scientific Reports
View all journals

Subjects

Biological Sciences
Scientific Community & Society
Earth & Environmental Sciences
Health Sciences
Physical Sciences
View all subjects

Contact us
Authors & Referees
Librarians
Advertisers
Press
About Nature Research

Search

Article search

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

nature.com sitemap

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
Nano
Protocol Exchange
Nature Index

Publish with us

Guide to Authors
Guide to Referees
Editorial policies
Open access
Reprints & permissions

Researcher services

Research data
Language editing
Scientific editing
Nature Masterclasses
Nature Research Academies

Libraries & institutions

Librarian service & tools
Librarian portal
Open research

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Career development

Nature Careers
Nature Conferences
Nature events

Regional websites

Nature China
Nature India
Nature Japan
Nature Korea
Nature Middle East

Refine your results by…

Filters ​

Filter By:

Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma

Crystal structure of the RNA-binding domain from transcription termination factor rho

Fludarabine phosphate for the treatment of low grade lymphoid malignancy

Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect

The NMR structure of the RNA binding domain of E.coli rho factor suggests possible RNA–protein interactions

Search

Quick links

Filters